Testing the Effect of the InsuPad Device in Daily Life Conditions

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 145 participants.

Also called NCT01594801

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 145 participants (enrolled count) (from the registry)
Sponsor
Insuline Medical Ltd. (from the registry)
Registry
  • NCT NCT01594801
Other papers using this trial's data
  • The Barmer study: impact of standardized warming of the injection site to enhance insulin absorption and reduce prandial insulin requirements and hypoglycemia in obese patients with diabetes mellitus Current medical research and opinion, 2014-05 DOI, PubMed 24392996

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01594801. Randomized; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2013-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Testing the Effect of the InsuPad Device in Daily Life Conditions
Condition
Diabetics Mellitus Type 1
Condition
Diabetes Mellitus Type 2
Intervention (Device)
InsuPad
Lead sponsor
Insuline Medical Ltd. (class: industry)

Record details

Record id
cardio:ct-nct01594801
Content hash
b62bfe26aae1b1beb83685f01c5a62542594e25eb6bfa6bc959a7caeb45f3b42